23-01-09 Navigating Contraceptive Hormones (NCC Code 4) Faculty
Kelley Borella DNP, APRN, WHNP-BC
Assistant Professor, Director of NP Pathway-MSN
University of Alabama
Shareen El-Ibiary PharmD, BCPS, FCCP
Professor and Department Chair, Pharmacology Practice
College of Pharmacy, Midwestern University
Approval
CE Approval Period: Now through Jan 10, 2025 (available for purchase until Jan 3, 2025)
This activity has been approved for 1.0 continuing education contact hours.
No refunds will be issued if the activity is not completed within the approval period.
Objectives
1. Review general pharmacology of contraceptive hormones.
2. Identify current product updates.
3. Discuss latest products available on the market.
Accreditation Statement
This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health (NPWH) for 1.00 continuing education contact hours. The program has been issued NPWH Activity number 23-01-09.
NPWH is approved by the California Board of Registered Nursing, CEP Number 13411
NPWH is committed to ensuring that educational sessions are free from commercial bias and product promotion. Any commercial products, goods or services displayed or discussed in this CE activity should not be interpreted to imply endorsement by NPWH.
NCC Code
This activity is coded by NCC as Code 4
Faculty Disclosures
Kelly Borella has no reported disclosures
Shareen El-lbiary has no reported disclosures
Successful Completion
Requires participants to:
- Read the objectives, disclosures, and disclaimers.
- Watch the activity and review the handout.
- Complete the session evaluation.
- Print your CE certificate.
- Go to your profile to view all earned certificates.
Commercial Support
This activity was supported by an educational grant from Mayne Pharma
